Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | birinapant | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.7 |
mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |